DudeDiligence.

THE WIRE

What insiders and companies just did: insiders buying and selling with their own money, company news, new 5% stakes and new shares registered.

BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing

Key

BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing

Newest first. Insider rows are open-market purchases and sales; several by one company are one row, open it for each.

  1. RACDResearch Alliance Corp IVPassive stake of 5% or more (13G), filed by Balyasny Asset Management.−0.4%13G ↗
  2. SMMTSummit Therapeutics IncOther events.−29.7%8-K 8.01 ↗
  3. YUMCYum China Holdings, IncA director bought $248K of stock.$248K−2.1%Form 4 ↗
  4. OSCROscar Health, IncOfficer or director change.−20.4%8-K 5.02 ↗
  5. HSICHenry Schein IncRegulation FD disclosure.−3.1%8-K 7.01 ↗
  6. ECORelectroCore, IncA director bought $54K of stock.$54K−15.8%Form 4 ↗
  7. RZLTRezolute, IncMaterial agreement and Regulation FD disclosure.+7.3%8-K 1.01 ↗
  8. MSCSTUDIO CITY INTERNATIONAL HOLDINGS LtdA director bought $31K of stock.$31K+12.8%Form 4 ↗
  9. BHVNBiohaven LtdRegulation FD disclosure.−10.3%8-K 7.01 ↗
  10. ACRSAclaris Therapeutics, IncRegulation FD disclosure and other events.−12.2%8-K 7.01 ↗
  11. HOWLWerewolf Therapeutics, IncPassive stake of 5% or more (13G), filed by Balyasny Asset Management.−3.4%13G ↗
  12. XXII22nd Century Group, IncResults of operations.−56.3%8-K 2.02 ↗
  13. DOXAmdocs LTDA director bought $104K of stock.$104K−8.1%Form 4 ↗
  14. IORIncome Opportunity Realty Investors IncShareholder vote.0.0%8-K 5.07 ↗
  15. KALAKALA BIO, IncOther events.+1846.0%8-K 8.01 ↗
  16. CUECue Biopharma, IncPassive stake of 5% or more (13G), filed by Balyasny Asset Management.−74.3%13G ↗
  17. MEDSDataMeds AI, IncMaterial agreement.+80.1%8-K 1.01 ↗
  18. SLXNSilexion Therapeutics CorpResults of operations.−33.8%8-K 2.02 ↗